WASHINGTON, DC – The American Medical Informatics Association (AMIA) is proud to announce the winners of the 2025 Edward H. Shortliffe Doctoral Dissertation Award. Yi Lin, PhD, of The Hong Kong University of Science and Technology, received the First Prize award with his dissertation titled "Towards Efficient Yet Effective Algorithms for Medical Image Segmentation." Yuzhe Yang, PhD, of the Massachusetts Institute of Technology, received Honorable Mention for his dissertation titled "Machine Learning Approaches that Extend Healthcare: Algorithms & Applications."
The awardees will be acknowledged at the AMIA 2025 Annual Symposium, November 15-19 in Atlanta. Drs. Lin and Yang will present their work to their informatics colleagues onsite during a scientific session at the Symposium.
The AMIA Edward H. Shortliffe Doctoral Dissertation Award offers high-value and prestigious recognition for the top doctoral dissertation each year that contributes to the science of informatics in any biomedical application domain or domains. Read the suggested guidelines published by JAMIA in 2016 for the preparation of high-quality dissertations in biomedical informatics.
"[Lin’s] research showcases an impressive blend of theoretical insights and practical applications," says Dr. Tim Kwang Ting Cheng, Vice-President for Research and Development, The Hong Kong University of Science and Technology.
"Yuzhe is an impactful researcher with keen insights and a fantastic collaborator," says Dr. Marzyeh Ghassemi, Assistant Professor, Massachusetts Institute of Technology.
###
About AMIA
AMIA is the professional home for more than 5,500 informatics professionals, representing frontline clinicians, researchers, public health experts, and educators who bring meaning to data, manage information, and generate new knowledge across the research and healthcare enterprise. As the voice of the nation's biomedical and health informatics professionals, AMIA plays a leading role in advancing health and wellness by moving basic research findings from bench to bedside, and evaluating interventions, innovations and public policy across care settings and patient populations.